Status:
COMPLETED
Levosimendan in High Risk Heart Valve Surgery
Lead Sponsor:
Kuopio University Hospital
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Prospective, randomized, double blind study investigating the efficacy of levosimendan in heart failure after cardiac surgery. Study hypothesis: Levosimendan diminishes the need for adrenergic inotro...
Detailed Description
200 patients are prospectively randomized in a double blind study investigating the efficacy of levosimendan in heart failure after cardiac surgery. Levosimendan/placebo is administered as 24 hour con...
Eligibility Criteria
Inclusion
- Eligible for cardiac valve or combined CABG and cardiac valve surgery:
- Clinical signs of cardiac insufficiency
Exclusion
- Endocarditis
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00154115
Start Date
March 1 2005
End Date
December 1 2008
Last Update
January 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University Hospital
Kuopio, Finland, 70210